Sunday, October 22, 2017
Home Authors Posts by Cell Tribune

Cell Tribune

38 POSTS 0 COMMENTS
CellTribune.com provides business and research news updates for the cell and gene therapy industry. CellTribune follows the companies and people who drive innovation in this exciting technology. The goal of CellTribune is to be recognized as the media leader and the go-to source for originally-reported, quality news coverage in this industry. We strive to become the link between budding companies, analysts and institutional investors. Submit your press release to Cell Tribune for immediate publication.

Landmark Bill Helps Regulation Catch Up to 21st Century Stem Cell...

LA JOLLA, Calif., Dec. 19, 2016 - History is in the making as the 21st Century Cures Act, a landmark piece of legislation focused on medical...

Clinical study tests adult stem cell therapy for infants with congenital...

In a first-in-children randomized clinical study, medical researchers at the University of Maryland School of Medicine (UM SOM) and the Interdisciplinary Stem Cell Institute...

Bionic Pancreas System Successfully Controls Blood Sugar Without Risk of Hypoglycemia

The bionic pancreas system developed by Boston University (BU) investigators proved better than either conventional or sensor-augmented insulin pump therapy at managing blood sugar levels in...

Keck Medicine of USC Receives $2.5 Million for translational osteoarthritis research

Funding will support the development of an off-the-shelf stem cell therapy that could be cheaper and less invasive than joint replacement surgery. "The rapidly growing...

Pluristem and Sosei CVC to Establish a New Corporation for the...

Pluristem and Sosei CVC will establish a new corporation which will pursue the clinical development and commercialization of PLX-PAD in Japan The first...

Juno Therapeutics’ and Celgene Corporation’s Investigational Drug JCAR017 Granted Breakthrough Therapy...

- Early results recently announced with JCAR017 in non-Hodgkin lymphoma and pediatric acute lymphoblastic leukemia -- Pivotal DLBCL trial expected to begin in 2017 SEATTLE &...

BioLife Solutions Executes 10 Year Supply Agreement with TissueGene for CryoStor®...

BOTHELL, Wash., - BioLife Solutions, Inc. (NASDAQ: BLFS), a leading developer, manufacturer and marketer of proprietary clinical grade cell and tissue hypothermic storage and cryopreservation...

Purdue Pharma and Exicure Announce Strategic Research Collaboration Agreement to Discover...

Purdue Pharma Will Obtain Full Worldwide Development and Commercial Rights to AST-005, as well as an Option to Three Additional Collaboration Targets with Associated...